Anonymous ID: eb3e1b March 12, 2020, 10:18 p.m. No.8397615   🗄️.is 🔗kun   >>7731

>>8396885 (lb)

>2. They want a specific kind of test, one that’s made to produce false positives (panic)

>Bingo! That's why pres wont allow WHoO's test kits. I want to know if those tests are helping to spread the virus

How did Europe not prepare in time when a German company had a test before anyone else?

>>8394860 (pb)

DJT RT

https://twitter.com/BW/status/1238209711339642881

https://www.bloomberg.com/news/articles/2020-03-12/a-berlin-biotech-company-got-a-head-start-on-coronavirus-tests

 

TIB Molbiol Syntheselabor GmbH, the Berlin biotech company he started three decades ago. “We’re nearing our limit.”

In the past two months, Landt and his staff at the company’s production facility—a former industrial building just south of the disused Tempelhof airport——have produced 40,000 coronavirus diagnostic kits, enough for about 4 million individual tests. TIB has reoriented its business toward coronavirus, running its machines through the night and on weekends to make the kits, which sell for about €160 ($180) apiece. As orders have poured in from the World Health Organization, national health authorities, and laboratories in some 60 countries, TIB’s revenue tripled…

>>8395095 (pb)

>https://www.gene-quantification.de/tib-molbiol/

>Collaborations

>Merck KG aA, Darmstadt

>Mayo Clinic, Rochester

>Roche Diagnostics GmbH

Anonymous ID: eb3e1b March 12, 2020, 10:35 p.m. No.8397731   🗄️.is 🔗kun   >>7762 >>7863 >>7965 >>8070 >>8210

>>8397615

>>Roche Diagnostics GmbH

Just out within the hour. FDA just walked right into a trap

March 13, 2020 00:52 ET | Source: F. Hoffmann-La Roche Ltd

Roche’s cobas SARS-CoV-2 Test to detect novel coronavirus receives FDA Emergency Use Authorization and is available in markets accepting the CE mark

First commercial test for SARS-CoV-2 will enable expedited coronavirus testing to meet urgent medical needs

Basel, 13 March 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the cobas® SARS-CoV-2 Test. It is intended for the qualitative detection of SARS-CoV-2, the virus that causes COVID-19 disease, in nasopharyngeal and oropharyngeal swab samples from patients who meet COVID-19 clinical and/or epidemiological criteria for testing. Hospitals and reference laboratories can run the test on Roche’s fully automated cobas® 6800 and cobas® 8800 Systems, which are widely available in the U.S. and around the world.

 

Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system.

Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. More than thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines,

The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2019 employed about 98,000 people worldwide.

 

https://www.globenewswire.com/news-release/2020/03/13/2000028/0/en/Roche-s-cobas-SARS-CoV-2-Test-to-detect-novel-coronavirus-receives-FDA-Emergency-Use-Authorization-and-is-available-in-markets-accepting-the-CE-mark.html